Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors

作者:Kongtim P; Adekola K; Milton D R; Ramlal R; Jimenez A; Chen J; Rondon G; Ahmed S; Kebriaei P; Betul O; Hosing C M; Popat U; Khouri I; Jabbour E; Cortes J E; Kantarjian H M; Champlin R E; Ciurea S O*
来源:Leukemia, 2017, 31(7): 1654-1657.
DOI:10.1038/leu.2017.118